| AKT | protein kinase B |
| APC | APC regulator of Wnt signaling pathway |
| ATM | adjacent tissue myofibroblast |
| BCSC | breast cancer stem cell |
| BE | Barrett’s esophagus |
| BPH | benign prostatic hyperplasia |
| CA125 | cancer antigen 125 |
| CA 15-3 | cancer antigen 15-3 |
| CAM | cancer associated myofibroblast |
| CCRL2 | C-C Chemokine Receptor-Like 2 |
| CEA | carcinoembryonic antigen |
| chemerin1 | chemerin receptor 1 |
| chemerin2 | chemerin receptor 2 |
| CK-1 | casein kinase 1 |
| CMKLR1 | Chemokine-Like Receptor 1 |
| CRP | C-reactive peptide |
| CYFRA 21-1 | cytokeratin 19 fragment 21-1 |
| ECM | extracellular matrix |
| EMT | epithelial-to-mesenchymal transformation |
| ERK | extracellular-related kinase |
| GBM | malignant glioblastoma |
| GEPIA | Gene Expression Profiling Interactive Analysis |
| GM-CSF | granulocyte-macrophage colony-stimulating factor |
| GPR1 | G Protein-coupled Receptor 1 |
| GSK3β | glycogen synthase kinase 3β |
| GTEx | Genotype-Tissue Expression |
| HCC | hepatocellular carcinoma |
| HCS | high chemerin-secreting |
| hGC | human granulosa cells |
| IFN-I | type 1 interferon |
| IFNγ | interferon gamma |
| IFNγT | interferon γ-secreting T cells |
| IL-6 | interleukin-6 |
| IL-8 | interleukin-8 |
| JNK | c-jUN N-terminal kinase |
| KGN | human ovarian granulosa-like tumor |
| LCS | low chemerin-secreting |
| MAPK | mitogen-activated protein kinase |
| MD | moderately differentiated prostate cancer (Gleason 7) |
| mDC | myeloid dendritic cell |
| MDSC | myeloid-derived suppressor cells |
| MIF | macrophage inhibitory factor |
| MIP3α | macrophage inflammatory protein-3 alpha |
| MMP | matrix metalloproteinase |
| MSC | mesenchymal stromal cell |
| NASH | non-alcoholic steatohepatitis |
| NASH-HCC | non-alcoholic steatohepatitis with dimethylnitrosamine-induced hepatocarcinoma |
| NC CNS | non-cancer CNS disease |
| NF-κB | nuclear factor kappa B |
| NK | natural killer |
| NSCLC | non-small cell lung cancer |
| NTM | normal tissue myofibroblast |
| ODC | oligodendrocytoma |
| OPL | oral pre-malignant lesion |
| OSC | oesophageal squamous cancer |
| OSCC | oral squamous cell carcinoma |
| pRCC | papillary renal cell carcinoma |
| PD | poorly differentiated prostate cancer (Gleason ≥8) |
| pDC | plasmacytoid dendritic cell |
| PI3K | phosphoinositide 3-kinase |
| PKC | protein kinase C |
| PTEN | phosphatase and tensin homolog |
| PVTT-1 | portal vein tumor thrombus cells |
| PVTT-1-Che | chemerin-overexpressing portal vein tumor thrombus cells |
| SCCOT | squamous cell carcinoma of the oral tongue |
| TAM | tumor associated macrophage |
| TCGA | The Cancer Genome Atlas |
| TIMP-1 | tissue inhibitor of metalloproteinase 1 |
| TIMP-2 | tissue inhibitor of metalloproteinase 2 |
| TME | tumor microenvironment |
| TNM | tumor-node-metastasis |
| TPM | transcripts per kilobase million |
| Treg | regulatory T cell |
| VEGF | vascular endothelial growth factor |
| WD | well differentiated prostate cancer (Gleason score ≤ 6) |